Chitosan for mucosal vaccination

This publication has 27 references indexed in Scilit:

• A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery
  Vaccine, 2000
• Carbohydrate Biopolymers Enhance Antibody Responses to Mucosally Delivered Vaccine Antigens
  Infection and Immunity, 2000
• Mucosal immunity and tolerance: relevance to vaccine development
  Immunological Reviews, 1999
• Preparation of alginate gel beads containing chitosan salt and their function
  International Journal of Pharmaceutics, 1999
• Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles
  Vaccine, 1997
• Adjuvants for human vaccines—current status, problems and future prospects
  Vaccine, 1995
• Nanosphere and microsphere uptake via Peyer's patches: observation of the rate of uptake in the rat after a single oral dose
  International Journal of Pharmaceutics, 1992
• The role of nasopharyngeal lymphoid tissue
  Immunology Today, 1992
• The mucosal immune system: from fundamental concepts to vaccine development
  Vaccine, 1992
• Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches
  Journal of Controlled Release, 1990